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Executive Summary 
This study examines the medical costs of childhood obesity in Alaska, today and in the future. 
We estimate that 15.2% of those ages 2 to 19 in Alaska are obese. Using parameters from 
published reports and studies, we estimate that the total excess medical costs due to obesity for 
both adults and children in Alaska in 2012 were $226 million, with medical costs of obese 
children and adolescents accounting for about $7 million of that total.  
 
And those medical costs will get much higher over time, as today’s children transition into 
adulthood. Aside from the 15.2% currently obese, another estimated 20% of children who aren’t 
currently obese will become obese as adults, if current national patterns continue. We estimate 
that the 20-year medical costs—discounted to present value—of obesity among the current 
cohort of Alaska children and adolescents will be $624 million in today’s dollars.   
But those future costs could be decreased if Alaskans found ways to reduce obesity. We consider 
how reducing obesity in several ways could reduce future medical costs: reducing current rates 
of childhood obesity, rates of obese children who become obese adults, or rates of non-obese 
children and adolescents who become obese adults. We undertake modest reductions to 
showcase the potential cost savings associated with each of these channels. Clearly the financial 
savings are a direct function of the obesity reductions and therefore the magnitude of the realized 
savings will vary accordingly.   
 
Also keep in mind that these figures are only for the current cohort of children and adolescents; 
over time more generations of Alaskans will grow from children into adults, repeating the same 
cycle unless rates of obesity decline. And finally, remember that medical costs are only part of 
the broader range of social and economic costs obesity creates. 
  
	  
	  
Introduction and Methods 
The Centers for Disease Control and Prevention (CDC) estimates that 25.7% of Alaskan adults 
were obese in 2012.1  This is an adjusted estimate; the BRFSS defines adulthood as 18 years of 
age and older, while this study defines adults as 20 years of age and older. The CDC doesn’t 
estimate obesity among Alaska children and adolescents by age and sex. By using national rates 
from the National Center for Health Statistics to create Alaska-specific age and sex specific 
obesity rates, 2 we estimate that 15.2% percent of Alaskans ages 2 through 19—around 28,000 in 
2012—are obese.  
 
Weight status is assessed using the Body Mass Index (BMI). The CDC defines obese adults as 
having a BMI ≥ 30, and overweight adults as having a BMI between 25 and 29.9.3 For children 
and adolescents, obesity is defined as having a BMI at or above their age and sex specific 95th 
percentile cutoff point.4 
 
This paper provides the first estimates of the medical costs associated with obesity among 
children in Alaska today and in the future, as they become adults. Nationwide almost all those 
who are obese at ages 15 to 17—86% of obese boys and 90% of obese girls—remain obese as 
adults, and that 20.29% of boys and 20.97% of girls who were not obese as children become 
obese as they age.5 We don’t have the data to develop comparable parameters specifically for 
Alaska, so we use these nationwide parameters to estimate the additional costs attributable to 
obesity as children transition into adolescence and then adulthood. We also use the estimate 
developed by Finkelstein et al6 of the difference in annual medical costs between obese and non-
obese people nationwide—$1,429—as a basis for our estimates. We use the Bureau of Labor 
Statistics medical care CPI to adjust this figure for inflation.7 
 
Specifically, we estimate the aggregate medical costs associated with obese Alaska children and 
adolescents in 2012, and then look at costs over 20 years—discounted to today’s dollars—as 
those obese children age, and as additional Alaskans who were not obese as children become 
obese adults. We allow for cost increases in health care over time (i.e., medical care inflation) 
and discount future values at a rate of 7.0 percent per year. Discounting is used by economists 
	  
	  
when costs are to be incurred in the future. It is applied to make future costs comparable to 
current costs 
because consumers have a preference for current consumption compared to future consumption. 
Because health-related costs limit the funds available for consumption, a consumer would prefer 
to postpone payment of a given cost and the resulting reduction in consumption into the future. 
The current value of a given dollar amount to a consumer is therefore less if it has to be paid in 
the future than if it is incurred today. For this specific case, discounting means that costs incurred 
near the end (e.g., 15 to 20 years) of analysis are not as influential as ones incurred near the 
present in generating our cost estimate. In effect, it allows us to measure the savings in today’s 
dollars, so we have an accurate picture of their relative importance.	   There is no consensus 
regarding a fixed discount rate value but it typically ranges from 3-5%. We choose to use 7% as 
a conservative estimate given that most obesity related costs are incurred later in life, while the 
oldest people in our simulation are aged 39 by the end of our window of analysis. 
 
Finally, we look at how reducing rates of obesity—either by reducing the percentage of children 
who are obese or reducing how many remain or become obese as adults—could reduce future 
medical costs.  
 
Given the persistence of childhood and adolescent obesity into adulthood, and the low success 
rate in transitioning out of obesity in adulthood, 8 it is imperative to investigate earlier 
interventions. Before describing our findings, we first put this problem in context, by discussing 
why widespread obesity among children—in the U.S. and elsewhere—is so alarming. 
 
Background 
Obesity, once a condition exclusive to mature adults, has now become commonplace among 
children. The World Health Organization (WHO) declared childhood obesity to be one of the 
most serious public health challenges of the 21st century.9 In the U.S., 17% of children and 
adolescents between the age of 2 and 19 are obese.10 Childhood obesity is associated with a host 
of chronic diseases, such as type II diabetes,4 and can cause children serious psychological harm 
as a result of social stigmatization, depression, and poor body image.11-13 Childhood obesity had 
been linked to excess weight in adulthood with long-term consequences in direct (medical 
	  
	  
expenditure) and indirect (labor market) costs.14-15 If current childhood obesity trends continue, 
we can expect even greater increases in disability, morbidity, and premature death, as well as 
more losses in productivity.16 
 
The CDC reports that two in three Americans are overweight and one in three is obese;17 in 
2010, Colorado was the only state with an obesity rate below 20%. A recent Rand Institute 
report18 based on previous research19 finds that in 2020, up to one fifth of total health 
expenditures will be devoted to treating the consequences of obesity. The report also shows that 
obesity is linked to higher health-care costs than those related to smoking and drinking.20  
 
The medical costs, however, present only a partial picture of the total costs related to obesity, as 
obesity is also associated with loss of work-days and incidents of disability.21 Moreover, obese 
people may also be subject to social stigma and discrimination.22  
 
Literature Review 
To clarify the extent to which obesity influences health outcomes and personal and public 
expenditures, we provide a short literature review.  
 
Field et al23 used a ten-year follow up study of middle-aged women in The Nurses’ Health Study 
(NHS) and men in the Health Professionals Follow-up Study (HPFS) and found that being obese 
made men 10 times, and women 11.2 times, more likely to develop diabetes relative to those of 
normal weight (BMI<25). They also found both obese men and women about 2.5 times more 
likely to develop gallstones, and between 1.5 and 2 times more likely to develop heart disease, 
among other diseases.  
 
The illnesses mentioned above were among those with the highest out-of-pocket expenditures 
leading to bankruptcy driven by accumulation of medical costs for individuals who suffer from 
these diseases: on average $26,971 for diabetes, $23,380 for stroke and $21,955 for heart 
disease.24 In addition, there were significant expenses for treating not just the diseases that 
resulted from obesity but obesity itself: in 2006 alone, there were approximately 113,000 
	  
	  
bariatric surgeries performed in the United States, resulting in about $1.5 billion in medical 
expenses.25  
 
At the individual level, the health care costs incurred by obese people also tended to be higher 
than those incurred by their non-obese counterparts. Sturm19 showed that obesity was associated 
with a 36% increase in in-patient and out-patient spending and a 77% increase in medications. 
Finkelstein et al6 concluded that the annual U.S. medical costs attributable to obesity 
expenditures were $78.5 billion in 1998, and estimated that obesity-related expenditures had 
increased to $86 billion by 2008, based on estimates from the Medical Expenditure Panel 
Survey, or as much as $147 billion, based on the National Health Expenditure Data. 
 
Focusing on total payments, obese people cost $1,429 more than their non-obese counterpart 
across payers.6The fractions of expenditures attributable to obesity were 8.5% for Medicare 
spending, 11.8% for Medicaid spending, and 12.9% for private payer spending.6 The attributable 
fractions were calculated as the amount, or percent, by which medical costs per payer would 
decrease if all obese individuals became non-obese. Across all payers, the results from the 
Finkelstein study indicated that obesity was associated with a 9.1% increase in annual medical 
spending in 2006, compared with 6.5% in 1998. As we discuss later in the text, we use the 
$1,429 figure from MEPS to account for adult obesity costs in this study and adjust it for 
inflation, because we do not have information on the number of obese Alaskans across payers. 
An even more thorough review of the range of factors and or outcomes influenced by obesity, 
and the costs associated with each, was estimated by Hammond and Levine, 26   and is presented 
in appendix 1. 
 
Apart from the health costs, obesity is associated with a host of other indirect economic costs 
which we briefly discuss below. Our study makes no attempt to account for the indirect costs we 
enumerate, however. Therefore, it is best to think about our estimates as lower bound numbers. 
The economic costs of obesity-related morbidity have been documented in a number of studies.  
 
In an epidemiologic study of 10,825 employees, Tucker et al27 found that obese employees were 
1.74 and 1.61 times more likely to experience high and moderate levels of absenteeism, 
	  
	  
respectively, than were lean individuals. Burton et al28 found that employees at risk for an 
obesity-level BMI were more likely to have other health risks compared to those not at risk for 
an obesity-level BMI, and had twice as many sick days (8.45) as compared to those not at risk 
(3.73). Thompson et al29 found that the cost of obesity to U.S. businesses in 1994 was estimated 
at a total of $12.7 billion, including $2.6 billion as a result of mild obesity (BMI = 25-28.9) and 
$10.1 billion due to moderate to severe obesity (BMI ≥ 29). Using the 1994 National Health 
Interview Survey data, Wolf30 find that the indirect costs of obesity were 39.2 million excess 
work days lost, 239 million excess restricted activity days and 89.5 million excess bed days. 
 
Last but not least, obesity is also associated with social stigma, and obese people may suffer 
from discrimination; Carr et al22 (p250) used data from the Midlife Development in the United 
States (MIDUS) study, a national survey of more than 3,000 adults ages 25 to 74 in 1995, and 
found that compared to normal-weight people, people with a BMI of 35 or higher were more 
likely to report institutional and day-to-day interpersonal discrimination. Some of these issues 
resulted in non-economic costs that are difficult to quantify. For instance, obese non-professional 
workers were less likely than obese professional workers to report employment discrimination 
and interpersonal mistreatment. 
 
Methods 
Current Costs Nationwide and in Alaska 
Before tackling the Alaska questions, we first estimate nationwide costs related to obesity by 
first calculating the number of obese people (Table 1) by age group and gender using Ogden31 as 
the basis for obesity rates and the census as the source of population data. Once we generate 
these figures, we quantify the aggregate excess costs associated with obesity (Table 2) by 
multiplying the number of obese individuals by the average excess cost for each of these groups. 
The data on the excess medical costs are obtained from Finkelstein et al6 for adults, Trasande and 
Chatterjee32, and Trasande et al. 33 for children and adolescents.  
The aggregate estimates of U.S obesity costs calculated in this study are lower than those found 
in the Finkelstein et al6 study given that we use the average amount by which an obese person’s 
expenditures exceed those of their non-obese counterpart and apply that to the overall number of 
	  
	  
obese individuals1. Their approach in estimating the aggregates expenditures we can attribute to 
obesity is a function of the overall dollars devoted to medical expenditures. Our estimates are a 
combination of number of obese people and the average cost between an obese and a normal       
weight individual.  Additionally, aggregate estimates in their study are different because the cost 
differential varies by source of payment (provider) and type of service. They are able to generate 
increases in medical spending attributable to obesity by each type of service. Both this cost 
differential heterogeneity, along with the distribution of obese individuals across payment type - 
which we do not have, influence the results.  Furthermore, they impose attributable fractions 
generated from Medical expenditure panel survey, which only analyze the non-institutionalized 
population, onto the spending from the NHEA which include the people in institutions.   
We follow the same procedure as the one laid out above in determining the costs associated with 
obesity in Alaska (see Tables3 and 4).The procedure we reference simply indicates that we 
multiply the number of obese individuals for each of the age brackets by the average amount an 
obese person’s expenditures exceed those of their non-obese counterpart. Table 3 presents 
obesity statistics by age and gender for Alaska for the year of 2012. Alaska adjusted obesity rates 
are derived using national age and gender specific statistics and then adjusting them by the ratio 
of Alaska overall obesity rates relative to national overall obesity rates, allowing us to obtain 
specific age and gender rates for Alaska. Population figures are obtained from the US census, 
and based on these two data sources, we approximate that 162,829 Alaskans are obese. The 
obesity rates for Alaska children and adolescents are derived in a similar manner. The obesity 
rate for adults is 25.7% and for children and adolescents 15.2%. 
 
We draw on some of the more recent literature that has looked at medical costs attributable to 
obesity in childhood and adolescence for age specific cost differentials. For example, Trasande 
and Chatterjee32 find that childhood obesity is associated with an estimated $14.1 billion in 
additional prescription drug, emergency room and outpatient medical service costs annually. We 
use this and other33 estimates to calculate obesity costs by age group for children, shown in Table 
4.  
Future Costs for Alaska for a single cohort of Alaska children and adolescents  
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Our study draws from a number of the studies mentioned above and examines the medical costs 
of childhood obesity in Alaska. We first estimate the number of obese individuals and the 
aggregate excess medical costs associated with them in 2012. Then, we focus our attention on 
the cohort aged (2-19) by aging them for a twenty year period in order to see how these costs 
evolve as children transition into adolescence and adolescents into adulthood. This is important 
given that the obesity related costs vary by age. The twenty year window also allows for this 
entire cohort to transition into adulthood. The key parameters used in our simulation are the age 
specific current obesity rates, the gender specific probability an obese adolescent becomes an 
obese adult, and the gender specific probability a non-obese adolescent becomes an obese adult 
Essentially, we follow this cohort as it ages out and chronicle the expenses incurred each year 
given that a subset of them move into adolescence or adulthood, before discounting the costs 
them back to the present. 
 
We analyze both the overall medical costs (for adults and children/adolescents) incurred in 2012 
as well as the future ones (20-year medical discounted costs) as the current cohort of 2-19 year 
olds age and transition into adulthood.  
 
Detail of Findings  
Annual Medical Costs of Obesity 
Table 1 presents obesity statistics by age and gender for the United States for 2009 through 2010. 
Obesity figures are obtained from Ogden et al31 and population figures for 2012 are obtained 
from the US Census Bureau. Based on these two data sources, we approximate that 97 million 
Americans are obese. 
Table 2 presents data on the annual medical costs related to obesity, 6, 32, and 33 which are 
combined with the figures from Table 1 to generate overall costs. Using the above costs, we find 
that the annual obesity related medical costs nationwide in 2012 were $122.73 billion. As noted 
above, this amount differs from the much higher estimate in Finkelstein et al (2009), because we 
relied on the average annual individual cost difference between obese people and their non-obese 
counterparts—$1,429 (we adjust for inflation using the medical CPI)—and applied it to the 
obese population(See Appendix 2 for a summary of  cost derivation from Finkelstein).  
	  
	  
 
 
 
 
 
Table 4 presents data on the annual medical costs, 6, 32, 33 which are combined with the figures 
from Table 3 to generate overall costs for Alaska. Using the excess medical costs for the obese 
by age listed in column 3 of Table 4, we find that total excess or avoidable medical costs of 
obesity among adults and children in Alaska for 2012 is $226.8 million dollars, with $7.17 
million attributable to obese children and adolescents (ages 2 through 19). 
    
 
 
Future Medical Costs of Obesity: 
In addition to current obesity costs, there will be an accumulation of costs over time as obesity 
persists into adulthood. In an attempt to capture how childhood obesity can influence 
expenditures, we age the current cohort (ages 2-19) of Alaska children in order to examine how 
their costs accumulate as they gradually all move into adolescence and then adulthood. 
 
Table 5 presents information on the 20-year discounted medical costs associated with the current 
cohort of Alaska children and adolescents. A 20-year window allows the whole cohort to 
transition into adulthood. We conduct the analysis on a yearly basis but only report the 5-year 
increments. Given that the additional costs attributable to obesity are different for the 6-11 group 
than they are for the 12-19 group and eventually for adults, the overall costs increase as more 
children enter adulthood. The parameters used to simulate the model are listed below Table 5. 
Over the next 20 years, the present value (discounted medical costs) of excess obesity costs 
associated with this current cohort will be an estimated 624.3 million dollars. This is found by 
aging the 2-19 year old cohort 20 years into the future, calculating the costs incurred due to 
obesity, and then discounting those costs to the present value. 
 
	  
	  
	  
How much savings can be generated from modest reductions? 
The parameters displayed at the end of Table 5 in combination with the figures presented in 
Table 3 and Table 4 represent the starting points in estimating the 20-year discounted medical 
costs for this cohort of children and adolescents as explained above. Altering these parameters 
through interventions that decrease current childhood obesity rates, persistence, or likelihood of a 
non-obese adolescent becoming an obese adult can all be highly impactful. 
 
We proceed by targeting each of these parameters separately and investigating how a one 
percentage point reduction affects the cost savings generated through these different 
mechanisms. 
 
First, we simply estimate the 20-year discounted savings from reducing the rate of childhood 
obesity from 15.2 percent to 14.2 percent while holding everything else constant (Table 6). We 
find that such a cut in the obesity rate would decrease the present value of expenditures to 607.7 
million dollars from the baseline of 624.37 million resulting in a 16.8 million dollar saving. This 
simulation stems from an across the board 1 percentage point decrease in the obesity rate for all 
three subgroups (2-5, 6-11, 12-19).  
 
In an effort to shed some light regarding where most of the savings are coming from, we analyze 
the savings that can be generated by reducing the obesity rate for each group separately.  
 
Table 7: Reducing the obesity rate of 2-5 year olds by 1 percentage point: 
When we decrease the obesity rate from 10.64 to 9.64 percent for children between the ages of 2 
and 5, the 20-year discounted medical savings are $380,000. This figure is small, but 
unsurprising. This is largely due to the fact that the additional medical costs attributable to 
obesity in childhood and adolescence are not as pronounced as the ones incurred in adulthood 
and that our time frame is only 20 years. Also, the number of children who are obese at that age 
is not very large. Having said that, lifestyle changes at an early stage have a much better chance 
of being lifelong ones; these simple simulations are restricted to a 20-year window and do not 
capture other dimensions some of these early-stage interventions may influence 
	  
	  
Table 8: Reducing the obesity rate of 6-11 year olds by 1 percentage point: 
When we decrease the obesity rate from 16.45 to 15.45 percent, the 20 -year discounted medical 
savings are 3.48 million dollars. Unsurprisingly, this figure is larger than the one we find for the 
younger children due to the additional years spent in adulthood (i.e., more costs) for this 
subgroup. These differences are pronounced due to the time frame we impose on the modeling. 
Table 9: Reducing the obesity rate of 12-19 year olds by 1 percentage point: 
When we decrease the obesity rate from 16.65 to 15.67 percent, the 20-year discounted medical 
savings are 11.49 million dollars. This figure is considerably larger than the potential savings 
achieved from reducing the obesity rate for the other subgroups. It is clear, as we explain above, 
that the older children at the beginning of our simulations are the ones spending the longest time 
incurring costs attributable to obesity as adults during our 20-year window, resulting in increased 
costs. 
Now, we turn our attention to the other potential channels that can be targeted to generate 
financial savings.  
Table 10:  A 1 percentage point decrease in the transition of obese adolescents into obese adults 
Here we examine the savings that can be achieved by reducing the probabilities that currently 
obese adolescents become obese adults. We simulate a one percentage point decrease in both 
male and female transition rates. We estimate that 20-year discounted costs would decrease by 
2.9 million dollars if the probability of becoming an obese adult for male and female obese 
adolescents were to decrease from 86 to 85 percent and 90 to 89 percent respectively with the 
other parameters at their original values. An intervention such as the one described in this section 
is specifically targeting obese adolescents before entering adulthood and therefore attempts to 
alter behavior at a critical stage. We refer to this intervention age as critical given the evidence 
regarding the persistence of obesity past adolescence. 
 
Table 11: A 1 percentage point decrease in the transition of non-obese adolescents into obese 
adults 
 
	  
	  
We turn the focus to non-obese children and adolescents who become obese as they transition 
into adulthood and analyze the potential savings from a one percentage point reduction in the 
baseline transition rates. We find that that 20 -year discounted costs would decrease by 14.3 
million dollars if the probability of becoming an obese adult for male and female adolescents 
were to decrease from 20.29 to 19.29 percent and 20.97 to 19.97 percent, respectively, with the 
other parameters at their original values. It is important to note the savings are large because the 
number of non-obese adolescents exceeds that of their obese counterpart which means that 
preventing a larger portion of them from becoming obese adults pays dividends. 
  
 
 
 
Conclusion 
When assessing the magnitude of the 20-year medical costs of obesity, it is critical to keep in 
mind that these costs are related to the current cohort of Alaska children and adolescents. Over 
the next twenty years, additional medical costs of obesity in adults will also be incurred. In other 
words, Alaska adults who are currently obese and those who become obese over the next twenty 
years will have obesity-related costs in addition to those estimated for children and adolescents. 
Additionally and perhaps more importantly from a policy standpoint, the 20-year medical cost 
figure is only for the current cohort of children and adolescents, but does not include the medical 
costs of obesity related to future cohorts of children. As a simple illustration, a new cohort of 
residents aged five and younger will emerge in five years, and this group of children (and the 
cohorts that follow) will have medical costs of obesity over the next twenty years that are not 
figured in our analysis. Therefore, this analysis provides a snapshot that will continue to repeat 
itself, absent interventions to break the pattern. The analysis above shows there are many 
potential channels of curbing the obesity trend, all of which can result in substantial savings even 
when the obesity reductions are modest.  
This snapshot we describe, while illustrative, only captures a partial picture of the overall costs 
society faces when it comes to dealing with obesity. Limitations of the current study stem from 
factors such as not accounting for indirect costs,  having a relatively short 20 year follow up 
window, and the use average differences in expenditures between obese and their non-obese 
	  
	  
counterparts, and using a rather conservative discount rate to account for the fact that most 
obesity related expenditures occur late in life. 
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Figure 1: The CDC Growth Chart: BMI Criteria of Obesity for Children 
 
	  
	  
 
 
Source: U.S. Department of Health and Human Services (http://depts.washington.edu/growth/module7/text/page3b.htm) 
 
 
 
 
 
 
Figure 2: U.S. Trends in Obesity Among Children and Adolescents (1963-2008) 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  
	  
	  
Source: Centers for Disease Control and Prevention (CDC),  
http://www.cdc.gov/nchs/data/hestat/obesity_child_07_08/Figures1.png	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Table 1: Incidence of Obesity in the United States using 2012 population data: 
Age 
Cohort 
2012 
Population 
male 
2012    
Population 
female 
% Obese      
Male 
%Obese 
Female 
Obese 
Population 
Male 
Obese 
Population 
Female 
Obese 
Population 
Total 
Under 5 10,216,135 9,783,209 14.4 9.6 1,471,123 939,188 2,410,312 
5 to 9 10,459,193 10,016,343 20.1 15.7 2,102,298 1,572,566 3,674,864 
10 to 14 10,567,214 10,102,004 19.6 17.1 2,071,174 1,727,443 3,798,617 
15 to 19 10,962,861 10,397,841 19.6 17.1 2,148,721 1,778,031 3,926,752 
20 to 24 11,549,456 11,033,747 33.2 31.9 3,834,419 3,519,765 7,354,185 
25 to 29 10,844,886 10,553,440 33.2 31.9 3,600,502 3,366,547 6,967,050 
30 to 34 10,493,906 10,417,089 33.2 31.9 3,483,977 3,323,051 6,807,028 
35 to 39 9,714,613 9,773,586 33.2 31.9 3,225,252 3,117,774 6,343,025 
40 to 44 10,458,994 10,569,227 37.2 36 3,890,746 3,804,922 7,695,667 
45 to 49 10,726,625 10,962,854 37.2 36 3,990,305 3,946,627 7,936,932 
50 to 54 11,080,245 11,499,014 37.2 36 4,121,851 4,139,645 8,261,496 
55 to 59 10,068,409 10,704,108 37.2 36 3,745,448 3,853,479 7,598,927 
60 to 64 8,534,485 9,279,200 36.6 42.3 3,123,622 3,925,102 7,048,723 
65 to 69 6,606,856 7,370,497 36.6 42.3 2,418,109 3,117,720 5,535,830 
70 to 74 4,596,006 5,412,033 36.6 42.3 1,682,138 2,289,290 3,971,428 
75 to 79 3,291,452 4,198,131 36.6 42.3 1,204,671 1,775,809 2,980,481 
80 to 84 2,356,698 3,426,353 36.6 42.3 862,551 1,449,347 2,311,899 
85 to 89 1,964,033 3,923,297 36.6 42.3 718,836 1,659,555 2,378,391 
 154,492,067 159,421,973   47,695,743 49,305,862 97,001,605 
Notes: Obesity statistics are from Ogden CL, Carroll MD, and Kit BK. Flegal KM. Prevalence of Obesity in the 
United States-2010, National Center for Health Statistics Data Brief, no 82. Figures are subject to rounding. The 
Census Bureau computes state population estimates using multiple data sets, the most important of which is the 
decennial census. These figures above include birth rates, death rates and estimates of residents migrating from one 
state to another.  
 
	  
	  
Table 2: Estimated Annual Medical Costs of Obesity in the United States using 2012 population 
data: 
Age Cohort 
Obese Population 
Total 
Medical  cost (2012 
dollars per obese 
individual Estimated cost 
Under 5 2,410,312 NA  
5 to 9 3,674,864 151 556,652,922 
10 to 14 3,798,617 422 1,603,016,217 
15 to 19 3,926,752 422 1,657,089,161 
20 to 24 7,354,185 1,629 11,976,951,163 
25 to 29 6,967,050 1,629 11,346,466,716 
30 to 34 6,807,028 1,629 11,085,857,590 
35 to 39 6,343,025 1,629 10,330,187,409 
40 to 44 7,695,667 1,629 12,533,086,619 
45 to 49 7,936,932 1,629 12,926,007,477 
50 to 54 8,261,496 1,629 13,454,589,532 
55 to 59 7,598,927 1,629 12,375,536,079 
60 to 64 7,048,723 1,629 11,479,479,516 
65 to 69 5,535,830 1,629 9,015,596,253 
70 to 74 3,971,428 1,629 6,467,827,923 
75 to 79 2,980,481 1,629 4,853,981,108 
80 to 84 2,311,899 1,629 3,765,135,097 
85 to 89 2,378,391 1,629 3,873,423,172 
  97,001,605   139,300,883,955 
Notes. Data on the medical costs of obesity are from studies by Finkelstein et al. (2009), Trasande and Chatterjee 
(2009), and Trasande et al. (2009). Medical costs are adjusted for inflation and expressed in 2012 dollars using the 
medical care Consumer Price Index (2000 to 2012) of the U.S. Bureau of Labor Statistics. 
http://www.bls.gov/cpi/cpifact4.htm 
 
 
 
 
Table 3: Incidence of Obesity in Alaska: 
Age 
Cohort 
2012 
Population 
Male 
2012 
Female 
Population Total 
% Obese 
Male 
% Obese 
Female 
Obese 
Population 
Male 
Obese 
Population 
Female 
Obese 
Population 
Total 
2 to 5 22,129 20,543 42,672 12.5 8.6 2,771 1,771 4,542 
6 to 11 31,271 29,583 60,854 17.4 15.3 5,466 4,542 10,008 
12 to 19 41,932 38,463 80,395 17.0 16.2 7,147 6,261 13,407 
20 to 24 33,281 26,829 60,110 24.0 23.0 7,997 6,194 14,191 
25 to 34 58,634 52,476 111,110 24.0 23.0 14,089 12,116 26,205 
	  
	  
35to 39 23,325 21,758 45,083 24.0 23.0 5,605 5,023 10,628 
40 to 49 50,642 46,689 97,331 26.9 26.0 13,635 12,165 25,800 
50 to 59 56,370 52,076 108,446 26.9 26.0 15,177 13,569 28,746 
60 to 64 21,340 18,875 40,215 26.4 30.6 5,653 5,779 11,432 
65 plus 30,625 31,872 62,497 26.4 30.6 8,112 9,758 17,870 
         
 369,549 339,164 708,713   85,651 77,177 162,829 
Notes: The Census Bureau computes yearly state population estimates using multiple data sets, the most important 
of which is the decennial census. These figures above include birth rates, death rates and estimates of residents 
migrating from one state to another. Obesity statistics for children and adolescents are derived by first creating a 
ratio of obesity incidence in Alaska to that in the US from the 2011 Youth Risk Behavior Surveillance survey (10-
17). We then apply that ratio to national figures of obesity from study by Ogden et al. (2012) Figures are subject to 
rounding. This method allows us to create adjusted Alaska obesity rates by age and gender. For adults (20 and 
above), we adjust the national age and gender obesity rates by the ratio of Alaska to U.S obesity rates. 
 
 
 
 
 
 
Table 4: Estimated Annual Medical Costs of Obesity in the Alaska using 2012 population data: 
Age Cohort Obese Pop Cost in 2012 Dollars 
Estimated Medical Costs 
of Obesity 
2 to 5 4,542 N.A 0.00 
6 to 11 10,008 151.48 1,515,988.70 
12 to 19 13,407 422.00 5,657,863.60 
20 to 24 14,191 1,629 23,111,885.86 
25 to 34 26,205 1,629 42,676,845.19 
35to 39 10,628 1,629 17,309,037.38 
40 to 49 25,800 1,629 42,017,393.43 
50 to 59 28,746 1,629 46,814,912.39 
60 to 64 11,432 1,629 18,617,246.43 
65 plus 17,870 1,629 29,103,118.48 
    
 162,829  $ 226,824,291.46 
Notes. Data on the medical costs of obesity are from studies by Finkelstein et al. (2009), Trasande and Chatterjee 
(2009), and Trasande et al. (2009). Medical costs are adjusted for inflation and expressed in 2012 dollars using the 
(medical care) Consumer Price Index (2000 to 2012) of the U.S. Bureau of Labor Statistics.  
	  
	  
 
 
Table 5: Estimated 20 year Medical Costs of Obesity for Current Cohort of Alaska Residents 
between the ages of 2 and 19 
     
Years in 
Future 
Age 
Range 
Obese 
Population 
Estimated 
Medical Costs 
Costs Related to Currently obese Children and 
Adolescents 
5 7 to 24 34,834 90,265,645 59,276,308.45 
10 12 to 29 38,391 149,892,251 82,374,661.05 
15 17 to 34 41,459 185,076,495 91,454,511.65 
20 22 to 39 43,332 199,142,287 100,219,272.44 
  Total $624,376,679.51 $333,324,753.59 
Key Model Parameters: 
   %Currently Obese Children and Adolescents                                15.2% 
  % Obese Male Adolescents Who Become Obese Adults               86% 
  % Obese Female Adolescents Who Become Obese Adults           90% 
 % Non-Obese Male Adolescents Who Become Obese Adults       20.29% 
 % Non-Obese Female Adolescents Who Become Obese Adults    20.97% 
Notes: Medical costs are adjusted for inflation using historical data (2000 to 2012) from the medical care Consumer 
Price Index of the U.S. Bureau of Labor Statistics. Future values are discounted at a rate of 7.0 percent per year. 
Parameters on the obesity/non-obesity transitions between adolescence and adulthood are from a study by Freedman 
et al. (2005). 
Table 6:  Reduce Obesity rate for children between 2-19 by 1 percentage point 
 Years in 
Future Age Range 
Obese 
Population 
Estimated Medical 
Costs 
 5 7 to 24 33,080 86,773,201 
 10 12 to 29 36,909 145,359,253 
 15 17 to 34 40,315 180,355,703 
 20 22 to 39 42,556 195,215,973 
Total 
      607,704,131 
Savings             16,850,481 
    
Key Model Parameters: 
	  
	  
   %Currently Obese Children and Adolescents                                   14.2% compared to 15.2% 
  % Obese Male Adolescents Who Become Obese Adults                  86% 
  % Obese Female Adolescents Who Become Obese Adults              90% 
 % Non-Obese Male Adolescents Who Become Obese Adults         20.2% 
 % Non-Obese Female Adolescents Who Become Obese Adults     20.9% 
Notes: Medical costs are adjusted for inflation using historical data (2000 to 2012) from the (medical care) 
Consumer Price Index of the U.S. Bureau of Labor Statistics. Future values are discounted at a rate of 7.0 percent 
per year. Parameters on the obesity/non-obesity transitions between adolescence and adulthood are from a study by 
Freedman et al. (2005). 
 
 
 
 
 
 
Breakdown of the savings by age group: 
	  
	  
 
 
 
Table 7: Reduce Obesity rate for children  between 2-5 by 1 
percentage point 
                                Change 
  from  10.64%  -0.093 
  to 9.64%     
Estimated 20 year Medical Costs of Obesity for Current Cohort of Alaska 
Residents between the ages of 2 and 19       
   
Age Range                                    Obese Population         Estimated Medical Costs 
7 to 24 34,834 90,265,645.31 
12 to 29 38,391 149,892,251.43    
	  
	  
17 to 34 41,412 185,028,263.83 
22 to 39 43,271 198,809,688.94 
  623,995,849.51 
 
 Savings      $380,000 
	  
	  
Table 8: Reduce Obesity rate for children between 6-
11 by 1 percentage point 
     
                           
Change 
  from  16.45%  -0.0608 
  to 15.45%     
Estimated 20 year Medical Costs of Obesity for Current 
Cohort of Alaska Residents between the ages of 2 and 19 
    
Years in 
Future 
Age 
Range 
Obese 
Population 
Estimated Medical 
Costs 
5 7 to 24 34,302.93 89,860,070.53 
10 12 to 29 38,274.69 149,537,948.93 
15 17 to 34 41,164.79 183,690,970.62 
20 22 to 39 43,079.89 197,801,071.31 
      620,890,061.38 
Savings          $3,486,618 
	  
	  
Table 9:Reduce Obesity rate for children and 
adolescents between 12 to19 by 1 percentage point 
                      Change   
 from  16.65%          -0.05996   
  to 15.67%       
Estimated 20 year Medical Costs of Obesity for Current Cohort of 
Alaska  
Residents between the ages of 2 and 19 
    
Years in 
Future 
Age 
Range 
Obese     
Population Estimated Medical Costs 
5 7 to 24 33,760.03 87,481,829.96 
10 12 to 29 37,154.99 146,108,178.85 
15 17 to 34 40,738.04 182,119,136.17 
20 22 to 39 42,931.69 197,174,992.24 
     612,884,137.22 
Savings:  $11,492,542 
        
	  
	  
 	  
Table 10: 1 percentage point decrease in the transition of obese adolescents into obese adults	  
 
Years in Future Age Range 
Obese 
Population 
Estimated 
Medical Costs 
 5 7 to 24 34,769 89,966,449 
 10 12 to 29 38,264 149,241,593 
 15 17 to 34 41,275 184,184,806 
 20 22 to 39 43,153 198,256,807 
Total 
   
621,649,656 
Savings     2,904,957 
 
Key Model Parameters: 
   %Currently Obese Children and Adolescents                                    15.2% 
  % Obese Male Adolescents Who Become Obese Adults                  85% compared to 86% 
  % Obese Female Adolescents Who Become Obese Adults              89% compared to 90% 
 % Non-Obese Male Adolescents Who Become Obese Adults         20.2% 
 % Non-Obese Female Adolescents Who Become Obese Adults     20.9% 
 
 Table 11: 1 percentage point decrease in the transition of non-obese adolescents into obese 
adults 
 
Years in Future Age Range 
Obese 
Population 
Estimated 
Medical Costs 
 5 7 to 24 34,504 88,762,534 
 10 12 to 29 37,750 146,617,943 
 15 17 to 34 40,495 180,532,803 
 20 22 to 39 42,360 194,340,511 
Total       610,253,791 
Savings  14,300,822 
Key Model Parameters: 
   %Currently Obese Children and Adolescents                                  15.2% 
  % Obese Male Adolescents Who Become Obese Adults                  86%  
  % Obese Female Adolescents Who Become Obese Adults              90% 
 % Non-Obese Male Adolescents Who Become Obese Adults         19.2% compared to 20.2% 
 % Non-Obese Female Adolescents Who Become Obese Adults     19.9% compared to 20.9% 
	  
	  
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 1: 
Appendix: Summary of Obesity Costs 
Cost category Estimates/explanations Costs 
   
Medical spending Relative medical costs of overweight (vs normal 
weight) 
10-20% higher 
Relative medical costs of obese (vs normal weight) 36-100% higher 
Annual costs of childhood obesity 14.3 billion 
Nationwide annual “excess” medical spending 
attributable to overweight/obesity 
86-147 billion (total),  640 
million (women only) 
   
Productivity costs   
 Absenteeism Excess days of work loss due to obesity 1.02-4.72 days 
Relative risk ratio of having high absenteeism 1.24-1.53 times higher 
National costs of annual absenteeism from obesity $79-132 per obese person. 
$3.38-6.38 billion.  
	  
	  
$57,000 per employee (1998 
USD).  
$8 billion (2002 USD). 
Presenteeism Relative productivity loss due to obesity 1.5% or higher 
Disability Relative risk ratio of receiving disability income 
support 
5.64-6.92 percentage points 
higher 
Mortality Years of life lost due to obesity 1-13 years per obese person 
   
Human capital 
accumulation costs 
Days absent from school 1.2-2.1 schooldays 
Highest grade completed 0.1-0.3 fewer grades completed 
Source:  Hammond RA, Levine R. "The Economic Impact of Obesity in the United States. Diabetes Metab Syndr Obes, 
2010:3:28, 5-295. 
 
 
 
 
 
 
Appendix 2: 
National Estimates 
Finkelstein et al (2009) estimate additional costs that can be attributed to obesity in the following way: 
Using the medical expenditure panel survey data, they estimate obesity attributable fractions for each payer 
(Medicare/Medicaid/Private). The dependent variable in each case is payer specific spending and the explanatory 
variable are the respondent’s characteristics along with his/her BMI. The inclusion of an individual’s BMI in the 
regressions allows them to determine the impact of weight (specifically obesity) on medical expenditures (they use 
normal weight as the reference group). 
They calculate the average increase in medical spending attributable to obesity relative to normal weight by 
subtracting the predicted expenditures of each obese person when their obesity dummy variable is set 1, from 
average predicted spending for the same individual when the obesity variable is set to 0.  These obesity specific 
allow them to generate obesity attributable fractions: 
  OAF=Total Predicted Spending attributable to Obesity/ Total predicted Spending for the entire sample 
	  
	  
Their NHEA estimates are generated by multiplying the OAF’s times the total spending for the corresponding 
insurance category. 
State Specific Estimates: 
Trogdon et al (2011)  
In order to generate state level estimates, they supplement the national estimates described above with state 
representative data from the BRFSS. In essence, they combine the coefficients estimated from MEPS with the 
BRFSS state specific data. The OAF at the state level is measured in a similar manner to the national procedure. 
Once the OAF is obtained, they multiply it by the total expenditures for the state of interest/payer of interest to get 
overall obesity attributable expenditures. Since BRFSS does not have information on insurance status at the 
individual, they allocated all people over 65 to Medicare and had to model the probability of having Medicaid. For 
example Alaska‘s OAF’s are: 
Alaska Medicaid obesity attributable fraction =9.6% (point estimate) 
Alaska’s Medicare obesity attributable fraction=13.5 %( point estimate) 
Alaska’s State Level obesity attributable fraction=10.5% (point estimate) 
The obesity attributable expenditures for the state are calculated by multiplying the fractions above times the overall 
expenditures by payer. 
